Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520258 · ClinicalTrials.gov registry record · NA
Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption
A NA study of Glucose Metabolism Disorder, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT02520258 is a NA study of Glucose Metabolism Disorder that has completed, run by Rockefeller University. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02520258, a NA study of Glucose Metabolism Disorder, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Experiments have shown that some artificial sweeteners like those in diet soda can cause changes in how the body responds to and uses sugar. These changes increase the chance of obesity, type 2 diabetes, and other metabolic diseases. In this study, the investigators plan to see if the most common artificial sweetener, aspartame (brand name Equal, NutraSweet), causes these changes. The investigators believe that if metabolic changes are observed in a person who consumes aspartame, then removing all aspartame from the diet might lead to a reversal of the changes and a normalization of test results.This would impact sweetener additives in our foods and thus decrease the incidence of obesity, diabetes, and the metabolic syndrome.
Conditions Studied
Interventions
- OTHER Oral glucose tolerance test (OGTT)
- OTHER Diet soda containing aspartame only
Study Locations (1)
New York
- The Rockefeller University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02520258
The ClinicalTrials.gov registry entry for NCT02520258 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glucose Metabolism Disorder appearing as the primary indexed condition, and to 2 interventions - of which Oral glucose tolerance test (OGTT) is the first listed.
NCT02520258 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02520258 about?
NCT02520258 is a clinical study titled "Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption". Experiments have shown that some artificial sweeteners like those in diet soda can cause changes in how the body responds to and uses sugar. These changes increase the chance of obesity, type 2 diabetes, and other metabolic diseases. In this study, the investigators plan to see if the most common ar...
What is the current status of trial NCT02520258?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2015-08. Estimated completion is 2019-06-25.
What conditions does trial NCT02520258 study?
This clinical trial studies the following conditions: Glucose Metabolism Disorder.
What interventions are being tested in trial NCT02520258?
The interventions under investigation include: Oral glucose tolerance test (OGTT) (OTHER), Diet soda containing aspartame only (OTHER).
Who is sponsoring clinical trial NCT02520258?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02520258 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.